|
CDCA4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64168678651322E-12 |
| Normal-vs-Stage2 |
1.365000E-01 |
| Normal-vs-Stage3 |
1.91546778438578E-12 |
| Normal-vs-Stage4 |
1.70000014065863E-10 |
| Stage1-vs-Stage2 |
1.427370E-04 |
| Stage1-vs-Stage3 |
1.263400E-01 |
| Stage1-vs-Stage4 |
4.327600E-02 |
| Stage2-vs-Stage3 |
1.95436000000049E-05 |
| Stage2-vs-Stage4 |
3.47060000005506E-06 |
| Stage3-vs-Stage4 |
4.634800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.056370E-03 |
| Normal-vs-Asian |
2.01080000428178E-08 |
| Caucasian-vs-AfricanAmerican |
5.509200E-01 |
| Caucasian-vs-Asian |
6.048200E-01 |
| AfricanAmerican-vs-Asian |
7.667800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65400027007934E-10 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
1.749610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62747593179802E-12 |
| Normal-vs-Age(41-60Yrs) |
1.64313007644523E-13 |
| Normal-vs-Age(61-80Yrs) |
1.32870000002505E-06 |
| Normal-vs-Age(81-100Yrs) |
2.23099999996368E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.030800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.214100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.867000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.965410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.068200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.913800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.010800E-04 |
| Classical-VS-Follicular |
1.11022302462516E-16 |
| Classical-VS-Other |
1.862220E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
7.32747196252603E-14 |
| Tall-VS-Other |
8.562300E-03 |
| Tall-VS-Normal |
2.91220381143376E-11 |
| Follicular-VS-Other |
1.272430E-01 |
| Follicular-VS-Normal |
5.525600E-01 |
| Other-VS-Normal |
1.350270E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3034000040667E-08 |
| Normal-vs-N1 |
1.42580003359427E-09 |
| N0-vs-N1 |
2.603200E-03 |
|
|
